Alternative Care in Patients With Auto-Immune Diseases
NCT04094259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121
Last updated 2026-03-27
Summary
Patients followed in Internal Medicine bring together favorable conditions for the use of alternative medicines. While some are recognized for their benefits, some can, on the contrary, harm the patient. It is therefore proposed to make a complete descriptive inventory of these practices, through an anonymized questionnaire. The main objective is the evaluation of the proportion of the use of alternative medicines in patients with in the department of Internal Medicine A
Conditions
- Auto-Immune Diseases
Interventions
- BEHAVIORAL
-
Questionnaire.
patients will respond to a specific questionnaire regarding the use of alternative medicine
Sponsors & Collaborators
-
University Hospital, Limoges
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-09
- Primary Completion
- 2021-12-01
- Completion
- 2021-12-01
Countries
- France
Study Locations
More Related Trials
-
Clinical Autoinflammatory Disease Cohort
NCT07126145 ·Status: NOT_YET_RECRUITING
-
Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period
NCT05974683 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Lymphocyte Sub-populations and Auto Immune Diseases
NCT03901664 ·Status: COMPLETED
-
Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
NCT03254823 ·Status: COMPLETED
-
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
NCT07085104 ·Status: RECRUITING ·Phase: PHASE1
-
Monitoring of Inflammatory Conditions
NCT05458531 ·Status: COMPLETED
-
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
NCT05000216 ·Status: TERMINATED ·Phase: PHASE2
-
The Incidence of Infection in Treatment of Low-dose IL-2 of SLE Patients
NCT04136106 ·Status: UNKNOWN
-
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus
NCT03421184 ·Status: COMPLETED ·Phase: NA
-
Autoantibodies Prevalence During Checkpoint Inhibitor Treatment
NCT04220034 ·Status: COMPLETED
-
Weaning of Immunosuppression in Nephritis of Lupus
NCT01284725 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases
NCT06757426 ·Status: NOT_YET_RECRUITING
-
The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice
NCT04558203 ·Status: COMPLETED
-
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
NCT04895696 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement
NCT05789017 ·Status: RECRUITING ·Phase: NA
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immunome Project Consortium for Autoinflammatory Disorders
NCT03919110 ·Status: COMPLETED
-
Monitoring the IMmUological TOXicity of Drugs
NCT03480529 ·Status: COMPLETED
-
Anti-infection of Low-does IL-2 in SLE
NCT02932137 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus
NCT01904812 ·Status: COMPLETED ·Phase: NA
-
A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia
NCT01345708 ·Status: COMPLETED ·Phase: PHASE2
-
Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune Hepatitis
NCT02900443 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT06916806 ·Status: RECRUITING ·Phase: PHASE1
-
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT05251415 ·Status: RECRUITING
-
The Efficacy and Safety of ITF2357 in AIS
NCT00442182 ·Status: UNKNOWN ·Phase: PHASE2